{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:50:58Z","timestamp":1791219058983,"version":"4.1.0"},"reference-count":78,"publisher":"American Physiological Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurophysiology"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:p> Involuntary movements (dyskinesia) are a common symptom of dopamine-replacement therapy in parkinsonian patients, neuroleptic drug treatment of mental patients, and tic disorders. Levodopa-induced dyskinesia has been shown to be associated with substantial reduction of firing rate in the internal part of the globus pallidus. This study characterizes the changes that occur in the activity of the substantia nigra pars reticulata (SNr) of non-parkinsonian (normal) monkeys with apomorphine (APO)-induced orofacial dyskinesia. We conducted extracellular recordings of SNr neurons of two monkeys before and after induction of orofacial dyskinesia by systemic administration of APO. Involuntary orofacial movements appeared a few minutes after the injections and lasted 20\u201340 min. Almost all recorded neurons changed their firing rate after APO injection (96%), and most declined (70%). The mean amplitude of decreases was also larger than that of increases (40 vs. 21% of the control rate). Changes in firing pattern were not significant on average. Pairs of SNr neurons were uncorrelated before APO injection, similar to the normal pallidum. However, unlike the increased correlations in the pallidum that accompany parkinsonism, orofacilal dyskinesia in non-parkinsonian monkeys was not associated with changes in correlation between SNr neurons. We conclude that normal monkeys treated with APO can model orofacial dyskinesia and tic disorders that are a consequence of dopaminergic over-activity. These symptoms appear to be more related to reduced firing rate of SNr neurons and thus to disinhibition of their targets, than to changes in pattern and synchronization. <\/jats:p>","DOI":"10.1152\/jn.01036.2003","type":"journal-article","created":{"date-parts":[[2004,5,4]],"date-time":"2004-05-04T00:38:28Z","timestamp":1083631108000},"page":"1973-1981","source":"Crossref","is-referenced-by-count":30,"title":["Discharge Rate of Substantia Nigra Pars Reticulata Neurons Is Reduced In Non-Parkinsonian Monkeys With Apomorphine-Induced Orofacial Dyskinesia"],"prefix":"10.1152","volume":"92","author":[{"given":"Alon","family":"Nevet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genela","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Saban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Fainstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagai","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1985.53.6.1417"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1985.54.2.433"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0270(00)00335-6"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0270(01)00339-9"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(82)80148-6"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1038\/35086062"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Blin O, Masson G, Azulay JP, Fondarai J, and Serratrice G. Apomorphine-induced blinking and yawning in healthy volunteers. Br J Clin Pharmacol 30: 769\u2013773, 1990.","DOI":"10.1111\/j.1365-2125.1990.tb03848.x"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.3.546"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)01563-1"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(99)02344-6"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1979.42.1.57"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(78)90146-7"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-04-01407.2002"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(90)90110-V"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.03-08-01599.1983"},{"key":"R16","unstructured":"Fahn S, Greene PE, Ford B, and Bressman SB. Movement disorders induced By dopamine receptor blocking agents. In: Handbook of Movement Disorders. Philadelphia: Current Medicine, 1998, p. 125\u2013133."},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100794"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Filion M, Tremblay L, and Bedard PJ. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 547: 152\u2013161, 1991.","DOI":"10.1016\/0006-8993(91)90586-K"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410260209"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.03-08-01586.1983"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(03)42006-2"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-18-07850.2002"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2000.80.3.953"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1983.49.5.1230"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1985.53.1.292"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1674"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10474"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra010032"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(89)90240-6"},{"key":"R30","unstructured":"Jenner P. Factors influencing the onset and persistence of dyskinesia in MPTP-treated primates. Ann Neurol 47: S90\u2013S99, 2000."},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(02)00115-3"},{"key":"R32","unstructured":"Jenner P and Marsden CD. Neuroleptic-induced tardive dyskinesia. Acta Psychiatr 87: 566\u2013598, 1987."},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(96)00081-7"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/106.3.643"},{"key":"R35","unstructured":"Karson CN, Staub RA, Kleinman JE, and Wyatt RJ. Drug effect on blink rates in rhesus monkeys: preliminary studies. Biol Psychiatry 16: 249\u2013254, 1981."},{"key":"R36","unstructured":"Kleven MS and Koek W. Differential effects of direct and indirect dopamine agonists on eye blink rate in cynomolgus monkeys. J Pharmacol Exp Ther 279: 1211\u20131219, 1996."},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(00)00299-0"},{"key":"R38","unstructured":"Lang AE. Surgery for levodopa-induced dyskinesias. Ann Neurol 47: S193\u2013S199, 2000."},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902890104"},{"key":"R40","unstructured":"Leckman JF, Peterson BS, King RA, Scahill L, and Cohen DJ. Phenomenology of tics and natural history of tic disorders. Adv Neurol 85: 1\u201314, 2001."},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.19.8861"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1152\/jn.2001.86.1.249"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-07-02855.2002"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200002)47:2<141::AID-ANA1>3.0.CO;2-6"},{"key":"R45","unstructured":"Martin RF and Bowden DM. Primate Brain Maps: Structure of the Macaque Brain. Amsterdam: Elsevier Sciense B. V, 2000."},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00484-M"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199901)14:1<45::AID-MDS1009>3.0.CO;2-F"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.10.1365"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/115.3.809"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/108.2.405"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1007\/BF00249793"},{"key":"R52","unstructured":"Mones RJ. Levodopa-induced dyskinesia in the normal rhesus monkey. Mt Sinai J Med 39: 197\u2013201, 1972."},{"key":"R53","doi-asserted-by":"publisher","DOI":"10.1038\/381245a0"},{"key":"R54","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199712)27:4<278::AID-SYN2>3.0.CO;2-9"},{"key":"R55","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1995.74.4.1800"},{"key":"R56","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199911)46:5<732::AID-ANA8>3.0.CO;2-Q"},{"key":"R57","unstructured":"Pearce RK. L-dopa and dyskinesias in normal monkeys. Mov Disord 14, Suppl 1: 9\u201312, 1999."},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(67)86597-4"},{"key":"R59","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-0618(00)00099-5"},{"key":"R60","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-03-j0006.2001"},{"key":"R61","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-22-08559.2000"},{"key":"R62","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(80)90422-9"},{"key":"R63","doi-asserted-by":"publisher","DOI":"10.1038\/285240a0"},{"key":"R64","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(98)00689-7"},{"key":"R65","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00844.2001"},{"key":"R66","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1986.55.4.660"},{"key":"R67","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.8.1329"},{"key":"R68","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902220208"},{"key":"R69","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10649"},{"key":"R70","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)05964-9"},{"key":"R71","unstructured":"Vidailhet M, Bonnet AM, Marconi R, Durif F, and Agid Y. The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease. Mov Disord 14 Suppl 1: 13\u201318, 1999."},{"key":"R72","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10517"},{"key":"R73","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199907)46:1<22::AID-ANA6>3.0.CO;2-Z"},{"key":"R74","unstructured":"Vitek JL and Giroux M. Physiology of hypokinetic and hyperkinetic movement disorders: model for dyskinesia. Ann Neurol 47: S131\u2013S140, 2000."},{"key":"R75","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.04-09-02369.1984"},{"key":"R76","doi-asserted-by":"publisher","DOI":"10.1152\/jn.01180.2002"},{"key":"R77","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(77)90801-0"},{"key":"R78","doi-asserted-by":"publisher","DOI":"10.1016\/S0042-6989(01)00066-9"}],"container-title":["Journal of Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/jn.01036.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T04:55:21Z","timestamp":1568004921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/jn.01036.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1152\/jn.01036.2003"],"URL":"https:\/\/doi.org\/10.1152\/jn.01036.2003","relation":{},"ISSN":["0022-3077","1522-1598"],"issn-type":[{"value":"0022-3077","type":"print"},{"value":"1522-1598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}